Volume 16, Number 2—February 2010
Research
Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA
Figure 5

Figure 5. Proportion of children receiving at least 1 dose of influenza vaccine in school-located clinics, by age and vaccine formulation selected, Hawaii, USA, 2007–08 influenza season. LAIV, live attenuated influenza vaccine; TIV, trivalent Influenza vaccine; Either, parent or guardian consented to administration of either vaccine formulation to their child. N = 60,694; excludes 66 children for whom vaccine formulation data were not available.
Page created: December 13, 2010
Page updated: December 13, 2010
Page reviewed: December 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.